← Leaderboards
Olivier Tillement
Dana-Farber Cancer Inst
$1,486,213
Attributed
$2,972,425
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $619.9K · FY2020–24$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,972,425 · 1
By mechanism
R01$2,972,425 · 1
Top collaborators
- Ross I. Berbeco5 shared
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Donald W. Kufe$50,160,456
- Geoffrey I Shapiro$18,639,470
- Wilfred Ngwa$5,702,695
- Nathanael Schiander Gray$36,761,550
- Kasisomayajula Viswanath$37,155,095
Others in their field
Other Emerging Leaders on “Drug Kinetics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$241,865,009
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,714,869
- Yunda Huang · Fred Hutchinson Cancer Center$53,780,853
- Leonard Freedmand · Leidos Biomedical Research, Inc.$52,916,621
- Susan Abushakra · Alzheon, Inc.$47,690,244
- Kathleen Maletic Neuzil · Emory University$27,014,427
Research focus
Drug KineticsDesignAortaDoseA549BismuthBlood VesselsBiodistributionBiologicalCancer CellBiomaterial CompatibilityCancer TherapyChemistryClinicClinically RelevantClinical PracticeClinical TranslationCollaborationsContrast EnhancedContrast ImagingContrast MediaDana-Farber Cancer InstituteCancer PatientEffective Therapy
Grant awards (5)
Translation of a Bismuth-Gadolinium Nanoparticle for MR-guided Radiation Therapy$566,253
R01 · FY2024 · CA
Translation of a Bismuth-Gadolinium Nanoparticle for MR-guided Radiation Therapy$593,049
R01 · FY2023 · CA
Translation of a Bismuth-Gadolinium Nanoparticle for MR-guided Radiation Therapy$594,964
R01 · FY2022 · CA
Translation of a Bismuth-Gadolinium Nanoparticle for MR-guided Radiation Therapy$598,257
R01 · FY2021 · CA
Translation of a Bismuth-Gadolinium Nanoparticle for MR-guided Radiation Therapy$619,902
R01 · FY2020 · CA